Saturday, June 24, 2017 6:32:22 PM
not for a very long time..they let many shareholders (including you) believe they were in fact producing tonnage of ms when they were in fact NOT doing so..
"The company never said they had any tons of anything."
correct...and when I mentioned that back in late 2014, you said kim already stated he would have tonnage by mid 2014..he didn't have to pr that he accomplished it..it should be considered a fait accompli..
"They have told us that the location that the PP was at could produce tons at full capacity."
what pp was this?..is it still producing ms?..
"I have speculated that they should have produced well over a ton over the years but I would say most of it was destroyed as the strains emerged."
utterly meaningless
"I would guess that Kim has quite a bit of MS but it won't be used for samples until the company has an operating farm."
yea...cause if you used it for samples to big companies, that could lead to partnerships and who knows what else...who wants that?..lol
"I don't think that blaming the company because someone was wrong in speculations makes any sense."
he also attributes much of his speculation to info from the company and ben..
"It definitely shouldn't be used as evidence that a company is bad in any way."
well kim sure doesn't need any help in making himself and the company look bad...his shoddy management does it well enough..
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM